{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:05:09Z","timestamp":1767146709654,"version":"build-2238731810"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ijcard.2016.03.185","type":"journal-article","created":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T02:45:54Z","timestamp":1458873954000},"page":"346-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cardiac sympathetic activity in 22q11.2 deletion syndrome"],"prefix":"10.1016","volume":"212","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3205-5183","authenticated-orcid":false,"given":"Derk O.","family":"Verschure","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Boot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th\u00e9r\u00e8se A.","family":"van Amelsvoort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Booij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berthe L.F.","family":"van Eck-Smit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Aernout","family":"Somsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hein J.","family":"Verberne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.03.185_bb0005","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/gim.2014.175","article-title":"Practical guidelines for managing adults with 22q11.2 deletion syndrome","volume":"17","author":"Fung","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.ijcard.2016.03.185_bb0010","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/pd.4613","article-title":"Prevalence of recurrent pathogenic microdeletions and microduplications in over 9,500 pregnancies","volume":"35","author":"Grati","year":"2015","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ijcard.2016.03.185_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e3182060469","article-title":"Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome)","volume":"90","author":"McDonald-McGinn","year":"2011","journal-title":"Medicine"},{"key":"10.1016\/j.ijcard.2016.03.185_bb0020","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/0888-7543(92)90316-K","article-title":"Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1\u2014q11.2.","volume":"12","author":"Grossman","year":"1992","journal-title":"Genomics"},{"key":"10.1016\/j.ijcard.2016.03.185_bb0025","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.biopsych.2013.07.021","article-title":"Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome","volume":"75","author":"Gothelf","year":"2014","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.ijcard.2016.03.185_bb0030","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/sj.npp.1301508","article-title":"Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome","volume":"33","author":"Boot","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ijcard.2016.03.185_bb0035","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1007\/s00259-008-0739-8","article-title":"AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures","volume":"35","author":"Boot","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijcard.2016.03.185_bb0040","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/jmg.2008.063800","article-title":"Premature death in adults with 22q11.2 deletion syndrome","volume":"46","author":"Bassett","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.ijcard.2016.03.185_bb0045","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/01.CIR.101.16.1960","article-title":"Relationship between regional cardiac hyperinnervation and ventricular arrhythmia","volume":"101","author":"Cao","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.03.185_bb0050","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","article-title":"Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView myocardial imaging for risk evaluation in heart failure) study","volume":"55","author":"Jacobson","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2016.03.185_bb0055","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/0735-1097(88)92608-3","article-title":"Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy","volume":"12","author":"Schofer","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2016.03.185_bb0060","first-page":"15","article-title":"Heterogeneity of cardiac sympathetic nerve activity and systolic dysfunction in patients with hypertrophic cardiomyopathy","volume":"43","author":"Shimizu","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijcard.2016.03.185_bb0065","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties","volume":"56","author":"Beck","year":"1988","journal-title":"J Consult Clin Psychol"},{"issue":"Suppl. 3","key":"10.1016\/j.ijcard.2016.03.185_bb0070","first-page":"133","article-title":"A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables","volume":"10","author":"Naber","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.ijcard.2016.03.185_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.ijcard.2016.03.185_bb0080","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2165\/00003495-200464200-00003","article-title":"Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management","volume":"64","author":"Haddad","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.ijcard.2016.03.185_bb0085","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1677\/joe.0.1230393","article-title":"Direct pituitary inhibition of prolactin secretion by dopamine and noradrenaline in sheep","volume":"123","author":"Thomas","year":"1989","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ijcard.2016.03.185_bb0090","first-page":"2530","article-title":"Endogenous catecholamines suppress thyrotropin secretion during the early follicular phase of the menstrual cycle","volume":"80","author":"Plosker","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijcard.2016.03.185_bb0095","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s00259-010-1491-4","article-title":"Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology","volume":"37","author":"Flotats","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.ijcard.2016.03.185_bb0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12149-009-0337-2","article-title":"Normal values for nuclear cardiology: Japanese databases for myocardial perfusion, fatty acid and sympathetic imaging and left ventricular function","volume":"24","author":"Nakajima","year":"2010","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.ijcard.2016.03.185_bb0105","first-page":"R165","article-title":"Different relationships of spillover to release of norepinephrine in human heart, kidneys, and forearm","volume":"275","author":"Kopin","year":"1998","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.ijcard.2016.03.185_bb0110","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/eurheartj\/ehn113","article-title":"Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review","volume":"29","author":"Verberne","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2016.03.185_bb0115","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1152\/physrev.1990.70.4.963","article-title":"Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions","volume":"70","author":"Esler","year":"1990","journal-title":"Physiol Rev"}],"updated-by":[{"DOI":"10.1016\/j.ijcard.2016.06.055","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000}}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316306179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316306179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T20:52:55Z","timestamp":1589230375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316306179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":23,"alternative-id":["S0167527316306179"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.03.185","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac sympathetic activity in 22q11.2 deletion syndrome","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.03.185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}